The FDA has approved Medicis’ hyaluronic acid with lidocaine dermal fillers, Restylane-L and Perlane-L. This approval was based on clinical data that demonstrated Restylane-L and Perlane-L to ...
NEWPORT BEACH, Calif. - Evolus, Inc. (NASDAQ: NASDAQ:EOLS), a performance beauty company, announced its Evolysse™ dermal fillers showed positive results in a pivotal clinical trial against competitor ...
NEWPORT BEACH, Calif.--(BUSINESS WIRE)-- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced positive topline ...
NEWPORT BEACH, Calif. - Evolus, Inc. (NASDAQ: NASDAQ:EOLS), known for its portfolio of beauty products, recently announced a milestone for its Evolysse™/Estyme® Lift dermal filler, demonstrating ...
NEWPORT BEACH, Calif. - Evolus, Inc. (NASDAQ: EOLS) has announced the publication of a study in the Aesthetic Surgery Journal that demonstrates the effectiveness of its Evolysse™ Form and Evolysse™ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback